Literature DB >> 2569933

Somatostatin and somatostatin analogues in oncology.

H Parmar1, A Bogden, M Mollard, B de Rougé, R H Phillips, S L Lightman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2569933     DOI： 10.1016/0305-7372(89)90013-3

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  10 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1997-10

Review 3.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

4.  Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014.

Authors:  J M Kuhn; C Basin; M Mollard; B de Rougé; C Baudoin; R Obach; G Tolis
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections.

Authors:  A I Günal; A Işik; H Celiker; O Eren; H Celebi; S Y Günal; C Lüleci
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

6.  Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery.

Authors:  Tamer Demir; Burak Turgut; Ulku Celiker; Ibrahim Ozercan; Fatih Ulas; Nuray Akyol
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

7.  Biological and clinical evaluation of lanreotide (BIM 23014), a somatostatin analogue, in the treatment of advanced breast cancer. A pilot study by the I.T.M.O. Group. Italian Trials in Medical Oncology.

Authors:  A Di Leo; L Ferrari; E Bajetta; C Bartoli; G Vicario; D Moglia; R Miceli; M Callegari; A Bono
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

8.  Therapeutic response to somatostatin analogue, BIM 23014, in metastatic prostatic cancer.

Authors:  H Parmar; C D Charlton; R H Phillips; L Edwards; J L Bejot; F Thomas; S L Lightman
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

9.  Somatostatin binding in human gastrointestinal tissues: effect of cations and somatostatin analogues.

Authors:  G V Miller; S R Preston; L F Woodhouse; S M Farmery; J N Primrose
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

10.  Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.

Authors:  V M Macaulay; I E Smith; M J Everard; J D Teale; J C Reubi; J L Millar
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.